Can bedaquiline be reimbursed?

Bedaquiline is a new anti-tuberculosis drug specifically used to treat multidrug-resistant tuberculosis (MDR-TB). Since its launch, bedaquiline has received widespread attention due to its remarkable efficacy in patients with refractory tuberculosis. In China, bedaquiline has been officially launched and included in the national medical insurance directory. This decision greatly reduces the financial burden on patients and allows more people to have access to treatment.

The price of bedaquiline is relatively high. Domestic bedaquiline is in the form of 100mg*24 tablets, and the price of a box is about 6,000 to 7,000 yuan. Since it is included in medical insurance, the actual payment varies by region. The specific proportion and reimbursement policy of medical insurance reimbursement need to be determined according to the regulations of the local medical insurance bureau and the management of the hospital pharmacy. Patients can obtain information on reimbursement ratios through local medical insurance policies and purchase drugs at hospital pharmacies or medical insurance designated pharmacies.

In comparison, the price of foreign bedaquiline is relatively low. The price of the Russian version of the original drug 100 mg 188 tablets is about more than 10,000 yuan, which is more economical and affordable compared with domestic prices. In addition, there are also generic drugs produced in India, with the same specifications (100mg188 tablets) priced at only more than 2,000 yuan. The ingredients and efficacy of generic drugs are basically the same as those of original drugs, but due to different production costs and marketing strategies, the price difference is significant.

Since bedaquiline has been included in medical insurance, patients who meet the conditions for medical insurance reimbursement can enjoy corresponding cost reductions. The specific reimbursement ratio and reimbursement process vary from region to region, and patients usually need to be diagnosed and prescribed in a medical insurance designated hospital. After the drug costs are reimbursed, patients only need to pay the out-of-pocket portion, which to a certain extent alleviates the financial pressure caused by high drug prices.

In general, the inclusion of bedaquiline in medical insurance provides a more accessible treatment option for tuberculosis patients, but patients still need to consult their local medical insurance agency or hospital to understand the detailed reimbursement policy.